Exploratory Study of MSLN-CAR T Cells Secreting PD1/CTLA-4 Nanoantibody for the Treatment of Advanced Solid Tumors
Clinical trial NCT06248697 · RECRUITING
Trial details
- NCT number
- NCT06248697
- Sponsor
- Shanghai Cell Therapy Group Co.,Ltd
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-01
- Primary completion
- 2026-07-30
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.